Distinct Cardiometabolic Profiles for Overweight/Obese People with Different Haptoglobin Phenotypes: A Cross-Sectional Study

Read full text Summarise with VIRAT
Authors: MoezAlIslam E. Faris, Rasha Elsherif Hassan, Naglaa M. Sherif, Samir M. Awadallah, Dana N. Abdelrahim, Mohammed R. A. Elhag, Omar Hammouda, Asma Almansoori, Jalal Taneera, Mohamed Ibrahim Madkour
Cited by: 0
References: 46

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: Haptoglobin (Hp) is an acute-phase protein crucial for neutralizing oxidative damage and eliminating free hemoglobin. However, the effect of Hp polymorphism on the modulation of anthropometric, metabolic, and inflammatory aspects of obesity remains poorly elucidated. Methods: Hp genotypes, glucometabolic and cardiometabolic markers, serum CD163, and pro-inflammatory and anti-inflammatory markers were assessed in conveniently recruited participants with overweight and obesity of the same racial and ethnic backgrounds. Results: A total of 114 participants (75 males, 39 females; mean age 37.32 ± 11.8 years) with overweight or obesity (BMI = 30.41 ± 5.09 kg/m2) were recruited. Participants with Hp2-1 and Hp2-2 genotypes showed significantly higher (P < 0.05) levels of insulin resistance, total cholesterol, LDL-C, and triglycerides than those with the Hp1-1 genotype. In contrast, participants with the Hp1-1 genotype had substantially higher (P < 0.05) serum Hp levels than those with the Hp2-2 genotype. Furthermore, participants with the Hp2-1 genotype expressed significantly higher (P < 0.05) levels of IL-6 and IL-10 than their counterparts with the Hp2-2 genotype. No significant differences were found in anthropometric measures, IGF-1, insulin sensitivity, HDL-C, CD163, and TNF-α. Conclusion: Hp polymorphism is remarkably associated with distinct metabolic and glucoregulatory aspects in individuals with overweight and obesity, with Hp2-1 and Hp2-2 genotypes associated with higher glucometabolic and cardiometabolic risks. The Hp genotype might serve as a predictive marker for diabetes and cardiovascular diseases. Further research is warranted on the clinical implications of Hp genotyping.

Fields of Study & Subjects

Adipokines Inflammation and Metabolic Diseases Hemoglobin structure and function Heme Oxygenase-1 and Carbon Monoxide

Publication details

Journal / source
Preprints.org
Publication date
25 March 2026
Language
EN
Document type
Preprint